GONGWIN BIOPHARM CO., LTD
Update:2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
PTS - MITTA
Founded Year
2014
Unified Business No.
24751115
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,285,978,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
OTC listing(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Gongwin Biopharm Holdings, Co., Ltd. Cayman (Gongwin-KY; ticker: 6617), founded in 2014, is a Taiwan-based biopharmaceutical company focused on developing novel anti-cancer drugs.
In 2017, Gongwin-KY was granted the "Biotech New Drug Company" designat
In 2017, Gongwin-KY was granted the "Biotech New Drug Company" designat